Trajenta

Trajenta Meets Primary Endpoint in Cardiovascular Trial
CP Wire
Thu, 07/19/18 - 09:47 am
Boehringer Ingelheim
Eli Lilly
Trajenta
Trajenta Meets Primary Endpoint in Cardiovascular Trial
Thu, 07/19/18 - 09:47 am
Boehringer Ingelheim
Eli Lilly
Trajenta
Diabetes Drug Shakeup: What You Need to Know About New FDA Warnings
Motley Fool
Tue, 04/19/16 - 09:50 am
FDA
diabetes
AstraZeneca
Takeda
Nesina
Onglyza
Eli Lilly
JNJ
Trajenta
Jardiance
Invokana
Eli Lilly/ Boehringer Drug Under FDA Review
Yahoo/Zacks.com
Tue, 04/15/14 - 04:49 pm
FDA
Eli Lilly
Boehringer Ingelheim
Trajenta
empagliflozin
diabetes
type 2 diabetes
Lilly, Boehringer diabetes drug Trajenta receives European marketing approval
Yahoo/AP
Thu, 08/25/11 - 01:28 pm
Eli Lilly
Boehringer Ingelheim
diabetes
Europe
Trajenta